Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Mazzaferro

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 26, 2015
Pro: cardiovascular calcifications are clinically relevantJordi Bover, Pieter Evenepoel, Pablo Ureña-Torres, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 19, 2020
[Peritoneal dialysis in the Lazio region: results from 2017 regional audit]Massimo Morosetti, Anna Rachele Rocca, Alessandro Domenici, et al.
BMC Nephrology|April 18, 2015
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational studyPiergiorgio Messa, Mario Cozzolino, Diego Brancaccio, et al.
Journal of Nephrology|November 13, 2023
Tubular changes in autosomal dominant polycystic kidney disease patients: observational studySilvia Lai, Adolfo Marco Perrotta, Silverio Rotondi, et al.
Journal of Nephrology|December 29, 2010
Management of secondary hyperparathyroidism in Italy: results of the Italian FARO surveySandro Mazzaferro, Diego Brancaccio, Piergiorgio Messa, et al.
International Journal of Nephrology and Renovascular Disease|January 8, 2015
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 studyDaniela Paola Roggeri, Mario Cozzolino, Sandro Mazzaferro, et al.
Journal of Nephrology|December 4, 2019
On the role of skin biopsy in the diagnosis of calcific uremic arteriolopathy: a case-based discussionSilverio Rotondi, Natalia De Martini, Lida Tartaglione, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2017
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general populationAdrian Covic, Marc Vervloet, Ziad A Massy, et al.
Journal of Translational Medicine|November 27, 2019
Renal involvement and metabolic alterations in adults patients affected by cystic fibrosisSilvia Lai, Sandro Mazzaferro, Anna Paola Mitterhofer, et al.
Kidney International Reports|May 20, 2024
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPSSuguru Yamamoto, Hanne Skou Jørgensen, Junhui Zhao, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 26, 2015
Pro: cardiovascular calcifications are clinically relevantJordi Bover, Pieter Evenepoel, Pablo Ureña-Torres, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 19, 2020
[Peritoneal dialysis in the Lazio region: results from 2017 regional audit]Massimo Morosetti, Anna Rachele Rocca, Alessandro Domenici, et al.
BMC Nephrology|April 18, 2015
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational studyPiergiorgio Messa, Mario Cozzolino, Diego Brancaccio, et al.
Journal of Nephrology|November 13, 2023
Tubular changes in autosomal dominant polycystic kidney disease patients: observational studySilvia Lai, Adolfo Marco Perrotta, Silverio Rotondi, et al.
Journal of Nephrology|December 29, 2010
Management of secondary hyperparathyroidism in Italy: results of the Italian FARO surveySandro Mazzaferro, Diego Brancaccio, Piergiorgio Messa, et al.
International Journal of Nephrology and Renovascular Disease|January 8, 2015
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 studyDaniela Paola Roggeri, Mario Cozzolino, Sandro Mazzaferro, et al.
Journal of Nephrology|December 4, 2019
On the role of skin biopsy in the diagnosis of calcific uremic arteriolopathy: a case-based discussionSilverio Rotondi, Natalia De Martini, Lida Tartaglione, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2017
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general populationAdrian Covic, Marc Vervloet, Ziad A Massy, et al.
Journal of Translational Medicine|November 27, 2019
Renal involvement and metabolic alterations in adults patients affected by cystic fibrosisSilvia Lai, Sandro Mazzaferro, Anna Paola Mitterhofer, et al.
Kidney International Reports|May 20, 2024
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPSSuguru Yamamoto, Hanne Skou Jørgensen, Junhui Zhao, et al.
Pageof 13